CC
Caxton Corporation’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-19,473
| Closed | -$133K | – | 13 |
|
|
2023
Q3 | $133K | Buy |
+19,473
| New | +$133K | 0.51% | 7 |
|
|
2019
Q1 | – | Sell |
-61,264
| Closed | -$453K | – | 27 |
|
|
2018
Q4 | $453K | Buy |
61,264
+21,509
| +54% | +$159K | 0.55% | 14 |
|
|
2018
Q3 | $577K | Buy |
39,755
+20,241
| +104% | +$294K | 0.53% | 14 |
|
|
2018
Q2 | $390K | Sell |
19,514
-1,628
| -8% | -$32.5K | 0.14% | 14 |
|
|
2018
Q1 | $370K | Buy |
21,142
+3,148
| +17% | +$55.1K | 0.4% | 17 |
|
|
2017
Q4 | $444K | Buy |
17,994
+7,818
| +77% | +$193K | 0.54% | 11 |
|
|
2017
Q3 | $263K | Buy |
10,176
+38
| +0.4% | +$982 | 0.27% | 14 |
|
|
2017
Q2 | $275K | Sell |
10,138
-3,125
| -24% | -$84.8K | 0.43% | 10 |
|
|
2017
Q1 | $395K | Buy |
13,263
+22
| +0.2% | +$655 | 1.13% | 6 |
|
|
2016
Q4 | $359K | Buy |
+13,241
| New | +$359K | 1.22% | 6 |
|